Uwe Kordes practices in Hamburg, Germany. Kordes is rated as an Elite expert by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Rhabdoid Tumor Predisposition Syndrome, Rhabdoid Tumor, Cerebral Ventricle Cancer, Choroid Plexus Carcinoma, and Bone Marrow Transplant.
Mark Dickson is a Hematologist Oncology expert in New York, New York. Dickson has been practicing medicine for over 20 years and is rated as a Distinguished expert by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. He is also highly rated in 33 other conditions, according to our data. His top areas of expertise are Bone Tumor, Liposarcoma, Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, and Endoscopy. He is licensed to treat patients in New York. Dickson is currently accepting new patients.
Frederick Eilber is a Surgical Oncologist and a General Surgeon in Los Angeles, California. Eilber has been practicing medicine for over 28 years and is rated as a Distinguished expert by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. He is also highly rated in 32 other conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, and Fibrosarcoma. He is licensed to treat patients in California.
Summary: NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many years from the time they enroll. If you are interested in clinical testing please consider seeing a local genetic counselor or other genetics professional. If you have already had clinical genetic testing and meet eligibility...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.